Google Analytics is a powerful tool that tracks and analyzes website traffic for informed marketing decisions.
Service URL: policies.google.com (opens in a new window)
_gac_
Contains information related to marketing campaigns of the user. These are shared with Google AdWords / Google Ads when the Google Ads and Google Analytics accounts are linked together.
90 days
__utma
ID used to identify users and sessions
2 years after last activity
__utmt
Used to monitor number of Google Analytics server requests
10 minutes
__utmb
Used to distinguish new sessions and visits. This cookie is set when the GA.js javascript library is loaded and there is no existing __utmb cookie. The cookie is updated every time data is sent to the Google Analytics server.
30 minutes after last activity
__utmc
Used only with old Urchin versions of Google Analytics and not with GA.js. Was used to distinguish between new sessions and visits at the end of a session.
End of session (browser)
__utmz
Contains information about the traffic source or campaign that directed user to the website. The cookie is set when the GA.js javascript is loaded and updated when data is sent to the Google Anaytics server
6 months after last activity
__utmv
Contains custom information set by the web developer via the _setCustomVar method in Google Analytics. This cookie is updated every time new data is sent to the Google Analytics server.
2 years after last activity
__utmx
Used to determine whether a user is included in an A / B or Multivariate test.
18 months
_ga
ID used to identify users
2 years
_gali
Used by Google Analytics to determine which links on a page are being clicked
30 seconds
_ga_
ID used to identify users
2 years
_gid
ID used to identify users for 24 hours after last activity
24 hours
_gat
Used to monitor number of Google Analytics server requests when using Google Tag Manager
1 minute
Know what’s an even better deal than new biologic drugs? Over-the-counter (OTC) drugs. If the FDA had a policy to seek out drugs that are safe enough for patients to self-administer and move them OTC Americans would save on drug prices and doctor visits. This should be the policy whether the patent holders like it or not. Of course, most would be off-patent by the time there is enough history to deem them safe enough for self-medication.
Thanks for posting the Obamacare’s Not Working website. There are a lot of good observations in the collected articles.
Sometimes the author does take a wide swing and tends to over-simplify problems. He pounds hard on the increasing premiums of Obamacare, for example. The hard fact is that guaranteed-issue health plans always have increasing premiums. Mark Pauly and Thomas Miller wrote a good article a few years ago on high-risk pools a few years ago that made this point in detail.
The author is appalled that persons making $200,000 a year can get subsidies. Well, the subsidy kicks in when health insurance costs more than about 8% of income. When this $200,000 family with no employer coverage faces a health insurance premium of $26,000 a year, this exceeds 8% of income and triggers a subsidy of about $10,000.
This hypothetical family may have health conditions, so short term insurance is not an option.
I don’t have a perfect solution, but a federal subsidy in this case is understandable.
John Goodman has been a strong, fact-based critic of Obamacare since before it was passed. In recounting its flaws, however, he and many others focus on fake goals rather than real goals. Marketplace plans were sold to the public as insurance products that would revitalize the individual market for health insurance. This was always unlikely, and by this standard, they have certainly failed. However, growing actuarially sound insurance products was not the real goal underlying passage of the ACA. Many of the architects of the legislation designed these plans to be a transition to universal taxpayer-supported health insurance. If you accept this as the real goal of Obamacare, it has been pretty successful. In 2020, over 80% of Exchange enrollees were getting some level of federal subsidy, and the federal government’s cost per enrollee was about $5,800 per member, more than the cost of Medicaid. Federal projections show total enrollment flat or declining through 2030, but the subsidy per enrollee is expected to grow 3% per year, to $8,600 by 2030. As this subsidy grows and employer-sponsored insurance becomes more and more expensive (because employers are cross-subsidizing Medicare and Medicaid), the pressure will build on small businesses to drop employer-sponsored health insurance and tell their employees to purchase coverage on the exchange. As a vehicle for growing taxpayer-supported healthcare, this may not be as efficient as increasing the eligibility thresholds for Medicaid enrollees, but every little bit helps.